Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07022574 · ClinicalTrials.gov registry record · NA
Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients
A NA study, sponsored by University of California, Los Angeles.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07022574 is a NA study that has not yet begun recruiting, run by University of California, Los Angeles. The registered enrollment target is 30 participants.
The verdict
NCT07022574, a NA study, has not yet begun recruiting, sponsored by University of California, Los Angeles.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study at UCLA Center for Health Sciences is testing whether the Autoimmune Protocol (AIP) diet can lower protein levels in the urine of people with IgA Nephropathy (IgAN), a common kidney disease that can lead to kidney failure. The AIP diet avoids foods that may cause inflammation (like dairy, grains, and sugar) for 8 weeks, then gradually reintroduces them over 4 months. We're enrolling 30 adults aged 18-65 with IgAN and protein in their urine to try this diet for 6 months. Participants will track their urine protein daily at home, keep a food log, and have monthly lab checkups, with support from a diet expert. The main goal is to see if the diet reduces urine protein by 20% or more, which could slow disease progression and reduce the need for treatments like dialysis. This exploratory study aims to find out if diet changes can help manage IgAN.
Interventions
- BEHAVIORAL Low inflammation diet intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07022574
The ClinicalTrials.gov registry entry for NCT07022574 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low inflammation diet intervention is the first listed.
NCT07022574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07022574 about?
NCT07022574 is a clinical study titled "Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients". This study at UCLA Center for Health Sciences is testing whether the Autoimmune Protocol (AIP) diet can lower protein levels in the urine of people with IgA Nephropathy (IgAN), a common kidney disease that can lead to kidney failure. The AIP diet avoids foods that may cause inflammation (like dairy,...
What is the current status of trial NCT07022574?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-01. Estimated completion is 2027-12-01.
What interventions are being tested in trial NCT07022574?
The interventions under investigation include: Low inflammation diet intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07022574?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.